Overview of Management Structure

President & CEO Konishi Takafumi

President & CEO

Konishi Takafumi

  • June 2023-Present

    President & CEO, Nippon Zoki Pharmaceutical Co., Ltd.

  • June 2022

    Director, Senior Managing Executive Officer, General Manager of Development Division, Nippon Zoki Pharmaceutical Co., Ltd.

  • May 2022

    Researcher, Orthopaedic Surgery, Graduate School of Medicine, Osaka University

  • June 2021

    Director, Managing Executive Officer, General Manager of Development Division, Nippon Zoki Pharmaceutical Co., Ltd.

  • June 2020

    Director, Executive Officer, Deputy General Manager of Development Division, Nippon Zoki Pharmaceutical Co., Ltd.

  • August 2018

    Manager of Planning Department, Development Division, Nippon Zoki Pharmaceutical Co., Ltd.

  • November 2016

    Development Division, Nippon Zoki Pharmaceutical Co., Ltd.

  • March 2015

    Completed Round 12 of the University of Tokyo Executive Management Program (UTokyo EMP)

  • April 2013

    Joined Nippon Zoki Pharmaceutical Co., Ltd.

  • April 2011

    Joined Maruho Co., Ltd.

Director Ujita Toshiko

Director

Ujita Toshiko

  • October 2022-Present

    Manager of Pharmaceutical Affairs Department, Development Division, Nippon Zoki Pharmaceutical Co., Ltd.

  • September 2022

    Member of Women‘s Empowerment Promotion Committee, Nippon Zoki Pharmaceutical Co., Ltd.

  • February 2021

    Member of Compliance Promotion Committee, Nippon Zoki Pharmaceutical Co., Ltd.

  • November 2020

    Chair of Safety Evaluation Committee for Investigational Drugs, Nippon Zoki Pharmaceutical Co., Ltd.

  • November 2020

    Chair of Clinical Trial Review Committee, Nippon Zoki Pharmaceutical Co., Ltd.

  • November 2016

    Section Chief of Pharmaceutical Affairs Department, Development Division, Nippon Zoki Pharmaceutical Co., Ltd.

  • September 2014

    Pharmaceutical Affairs Department, Development Division, Nippon Zoki Pharmaceutical Co., Ltd.

  • April 1990

    Joined Medical Affairs Department, Pharmaceutical Marketing Division, Nippon Zoki Pharmaceutical Co., Ltd.

  • March 1990

    Graduated from Department of Biopharmaceutical Science, Kobe Women’s College of Pharmacy

Outside Director Yamada Toshiharu

Outside Director

Yamada Toshiharu

  • 2018

    Established Biosciencepartners Inc.

  • 2012

    Vice President, Medtronic Japan Co., Ltd. Restorative Therapies Group

  • 2010

    Vice President, Director of Spine Navigation Division, Medtronic Sofamor Danek, Co., Ltd.

  • 1998

    Pharmaceutical Affairs and Quality Manager, SCM Manager, Medtronic Sofamor Danek, Co., Ltd.

  • 1996

    Manager of Marketing Department, Head of Navigation and Radiation Therapy Business, Kobayashi Sofamor Danek K.K.

  • 1993

    Marketing Department, Danek Japan Ltd.

  • 1987

    Surgical Division, Stryker Japan K.K.

  • 1980

    Maruki Medical Systems Inc.

  • 1977

    Joined a hospital

Corporate Auditor Miyashita Yoshiaki

Corporate Auditor

Miyashita Yoshiaki

  • June 2024-Present

    Corporate Auditor, Nippon Zoki Pharmaceutical Co., Ltd.

  • October 2023

    Compliance Office, Nippon Zoki Pharmaceutical Co., Ltd.

  • October 2022

    Head of Kobe Branch Office, Nippon Zoki Pharmaceutical Co., Ltd.

  • April 2019

    Head of Nagoya Branch Office, Nippon Zoki Pharmaceutical Co., Ltd.

  • June 2018

    Head of Kobe Branch Office, Nippon Zoki Pharmaceutical Co., Ltd.

  • April 1986

    Joined Pharmaceutical Marketing Division, Tokyo Branch Office, Nippon Zoki Pharmaceutical Co., Ltd.

Outside Corporate Auditor Tamaki Toshiko

Outside Corporate Auditor

Tamaki Toshiko

Certified Public Accountant

  • June 2024-Present

    Outside Corporate Auditor, Nippon Zoki Pharmaceutical Co., Ltd.

  • July 2023

    Corporate Auditor, Osaka City Bus Corporation (current position)

  • October 1989

    Ernst & Young ShinNihon LLC
    * She served as a comprehensive external auditor for multiple local governments on and after FY2011.